Rash associated with pregabalin use

Annals of Pharmacotherapy

Volumn 42, Issue 12, 2008, Pages 1899-1902

  Smith, Timothy L ^a   Baldwin, Aaron ^b   Cunningham Jr , Larry L ^b   Cook, Aaron M ^a,c  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UKHealthCare ^*

Author keywords

Antiepileptic drug; Pregabalin; Rash

Indexed keywords

DIPHENHYDRAMINE; GABAPENTIN; HYDROCORTISONE; LORATADINE; METHYLPREDNISOLONE; PREGABALIN;

ADULT; AMNESIA; ARTICLE; BURNING SENSATION; CASE REPORT; CONFUSION; DISORIENTATION; DROWSINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TRANSFORMATION; DRUG WITHDRAWAL; DYSESTHESIA; ERYTHEMA; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERKERATOSIS; INFERIOR ALVEOLAR NERVE; MACULOPAPULAR RASH; NERVE SURGERY; NEUROPATHIC PAIN; OFF LABEL DRUG USE; PRIORITY JOURNAL; PROBABILITY; PRURITUS; RASH; RISK FACTOR; SEDATION; SIDE EFFECT; THIRST;

ADMINISTRATION, ORAL; ADULT; ANALGESICS; ANTI-ALLERGIC AGENTS; DIPHENHYDRAMINE; DRUG ERUPTIONS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; NEURALGIA;

EID: 57449084351     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L305     Document Type: Article

References (12)

1. Freynhagen R, Grand S, Schüpfer G, et al. Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain enti-ties in clinical routine. Int J Clin Pract 2007;61:1989-96.
2. Kitchener JM. Glossopharyngeal neuralgia responding to pregabalin. Headache 2006;46:1307-8.
3. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006;67:1792-800.
4. Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-9.
5. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73.
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
7. Valeyrie-Allanore L, Sassolas B, Roujeau J-C. Drug-induced skin, nail and hair disorders. Drug Saf 2007;30:1011-30.
8. Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome. Drug Saf 1999;21:489-501.
9. Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia 2007;48:1360-5.
10. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007;48:1223-44.
11. Package insert. Lyrica (pregabalin). New York: Pfizer, Inc., June 2007.
12. Package insert. Neurontin (gabapentin). New York: Pfizer, Inc., January 2007.